ASIA unversity:Item 310904400/16889
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 90437/105768 (86%)
造访人次 : 10939685      在线人数 : 597
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/16889


    题名: Inhibition of Hedgehog signaling induces monocytic differentiation of HL-60 cells
    作者: 林振文;LIN, CHENG-WEN
    贡献者: 生物科技學系
    关键词: Sonic hedgehog homolog, cyclopamine, monocytic differentiation, Egr-1, Akt, ERK
    日期: 2012-06
    上传时间: 2012-11-23 17:18:07 (UTC+8)
    摘要: "There is little evidence to demonstrate the importance of the Sonic hedgehog homolog (Shh) pathway to differentiation therapy in the treatment of hematological neoplasms. Here we characterize the changes in acute myelogenous leukemia (HL-60) cells after blocking the Shh pathway by an antagonist of Smoothened, cyclopamine. Cyclopamine induces apoptosis of HL-60 cells in a dose- and time-dependent manner with increased G0/G1 cycle fraction. Treatment with cyclopamine increases the expression of monocytic cell markers CD11b and CD14, but the expression of CD13, CD33 and CD38 is unchanged. The monocytic differentiation of HL-60 cells induced by cyclopamine is also evidenced by an increase in Egr-1 expression. Importantly, cyclopamine down-regulates the phosphorylation of Akt and ERK, but activates AMP-activated protein kinase (AMPK) signaling. Further investigations should determine the clinical application of modulating the Shh pathway in the treatment of hematological malignancies.


    Read More: http://informahealthcare.com/doi/abs/10.3109/10428194.2011.639877"
    關聯: LEUKEMIA & LYMPHOMA
    显示于类别:[生物科技學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML98检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈